Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI.
第一作者:
Joseph E,Pero
第一单位:
Departments of Medicinal Chemistry, In Vitro Sciences, Psychiatry Research, Central Pharmacology, Drug Metabolism, Process and Analytical Chemistry, and Structural Chemistry, Merck Research Laboratories , P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486, United States.
作者:
DOI
10.1021/acsmedchemlett.5b00459
PMID
26985321
发布时间
2024-03-27
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



